Similar Search Results

The economics of research and development in the pharmaceutical industry

Comanor, William S. - In: Pharmaceutical innovation : incentives, competition, …, (pp. 54-72). 2007

Persistent link: https://www.econbiz.de/10003498965

Pharmaceutical economics since the 1960s : plus ça change, plus c’est la même chose

Comanor, William S. - In: International journal of the economics of business 22 (2015) 2, pp. 169-171

Persistent link: https://www.econbiz.de/10011405917

[Rezension von: Pharmaceutical innovation: revolutionizing human health, ed. by Ralph Landau ...]

Comanor, William S. - In: Journal of economic literature 39 (2001) 3, pp. 944-945

Persistent link: https://www.econbiz.de/10001612430

Pharmaceutical markets in Japan and the United States

Comanor, William S. - In: International journal of economic policy studies 16 (2022) 2, pp. 355-370

Persistent link: https://www.econbiz.de/10013433326

Mergers and innovation in the pharmaceutical market

Comanor, William S.; Scherer, Frederic M. - 2011

Persistent link: https://www.econbiz.de/10009487486

Mergers and innovation in the pharmaceutical industry

Comanor, William S.; Scherer, Frederic M. - In: Journal of health economics 32 (2013) 1, pp. 106-113

Persistent link: https://www.econbiz.de/10009703553

Pharmaceutical economics

Comanor, William S. (contributor); … - 2013

Persistent link: https://www.econbiz.de/10011498813

A special commemorative issue Honoring William S. Comanor and 50 years of pharmaceutical economics

Hay, Joel W. - In: International journal of the economics of business 22 (2015) 2, pp. 165-168

Persistent link: https://www.econbiz.de/10011405914

The political economy of the pharmaceutical industry

Comanor, William S. - In: Journal of economic literature 24 (1986) 3, pp. 1178-1217

Persistent link: https://www.econbiz.de/10001012281

Mergers and Innovation in the Pharmaceutical Industry

Comanor, William S. - 2012

Conflicting trends confound the pharmaceutical industry. The productivity of pharmaceutical innovation has declined in recent years. At the same time, the cohort of large companies who are the leading engines of pharmaceutical R&D has become increasingly concentrated. The concurrent presence of...

Persistent link: https://www.econbiz.de/10013096412